METHODS	A total of 1696 patients with early breast cancer , 1286 of whom were treated with either CMF-based adjuvant chemotherapy ( n = 410 ) , tamoxifen ( n = 656 ) or with a combination of the two ( n = 220 ) were considered for the present analysis .\